PUBLICATIONS
In Vitro Combinatorial Activity of Direct Acting Antivirals and Monoclonal Antibodies against the Ancestral B.1 and BQ.1.1 SARS-CoV-2 Viral Variants
Lia Fiaschi, Camilla Biba, Ilenia Varasi, Niccolò Bartolini, Chiara Paletti, Federica Giammarino, Francesco Saladini, Maurizio Zazzi and Ilaria Vicenti. Viruses 2024; https://doi.org/10.3390/v16020168
In-hospital mortality during the wild-type, alpha, delta, and omicron SARS-CoV-2 waves: a multinational cohort study in the EuCARE project
Pontus Hedberg, Milosz Parczewski, Karol Serwin, Giulia Marchetti, Francesca Bai, Björn-Erik Ole Jensen, Joana P.V. Pereira, Francis Drobniewski, Henrik Reschreiter, Daniel Naumovas, Francesca Ceccherini-Silberstein, Gibran Horemheb Rubio Quintanares, Matilu Mwau, Cristina Toscano, Florian König, Nico Pfeifer, Maurizio Zazzi, Iuri Fanti, Francesca Incardona, Alessandro Cozzi-Lepri, Anders Sönnerborg, Pontus Nauclér. The Lancet Regional Health – Europe 2024; https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(24)00021-8/fulltext
Serological screening in a large-scale municipal survey in Cascais, Portugal, during the first waves of the COVID-19 pandemic: lessons for future pandemic preparedness efforts
Sofia G. Seabra, Francisco Merca, Bernardo Pereira, Ivo Fonseca, Ana Cláudia Carvalho, Vera Brito, Daniela Alves, Pieter Libin, M. Rosário O. Martins, Mafalda N. S. Miranda, Marta Pingarilho, Victor Pimentel and Ana B. Abecasis. Front. Public Health 2024; https://doi.org/10.3389/fpubh.2024.1326125
Reducing Diagnostic Bias Through Multiplex Polymerase Chain Reaction (PCR) Testing for SARS-CoV-2, Influenza A/B, and RSV
Pontus Hedberg, John Karlsson Valik, Lina Abdel Halim, Tobias Alfvén, Pontus Naucler. Clinical Infectious Diseases 2024; https://doi.org/10.1093/cid/ciad747
Outcomes of Pediatric SARS-CoV-2 Omicron Infection vs Influenza and Respiratory Syncytial Virus Infections
Pontus Hedberg, Lina Abdel-Halim, John Karlsson Valik, Tobias Alfvén and Pontus Nauclér. JAMA Pediatr. 2023; doi:10.1001/jamapediatrics.2023.5734
Impact of the gut microbiome on immunological responses to COVID-19 vaccination in healthy controls and people living with HIV
Shilpa Ray, Aswathy Narayanan, Jan Vesterbacka, Ola Blennow, Puran Chen, Yu Gao, Giorgio Gabarrini, Hans-Gustaf Ljunggren, Marcus Buggert, Lokeshwaran Manoharan, Margaret Sällberg Chen, Soo Aleman, Anders Sönnerborg and Piotr Nowak. npj Biofilms Microbiomes 2023; https://doi.org/10.1038/s41522-023-00461-w
Long Term Assessment of Anti-SARS-CoV-2 Immunogenicity after mRNA Vaccine in Persons Living with HIV
Alessandra Vergori, Alessandro Cozzi-Lepri, Giulia Matusali, Stefania Cicalini, Veronica Bordoni, Silvia Meschi, Valentina Mazzotta, Francesca Colavita, Marisa Fusto, Eleonora Cimini, Stefania Notari, Veronica D’Aquila, Simone Lanini, Daniele Lapa, Roberta Gagliardini, Davide Mariotti, Giuseppina Giannico, Enrico Girardi, Francesco Vaia, Chiara Agrati, Fabrizio Maggi and Andrea Antinori. Vaccines 2023; https://doi.org/10.3390/vaccines11121739
SARS-CoV-2 trends in Italy, Germany and Portugal and school opening during the period of Omicron variant dominance: a quasi-experimental study
Federica Bellerba, Nils Bardeck, Michael Boehm, Oriana D’Ecclesiis, Sara Raimondi, Elisa Tomezzoli, Mafalda Silva Miranda, Inês Martins Alves, Daniela Alves, Ana Abecasis, Valeria Gabellone, Elisa Gabrielli, GiuliaVaglio, Elham Shamsara, Nico Pfeifer, Chiara Mommo, Francesca Incardona, Rolf Kaiser, Sara Gandini. International Journal of Infectious Diseases 2023; https://doi.org/10.1016/j.ijid.2023.11.002
Clinical outcomes during and beyond different COVID-19 critical illness variant periods compared with other lower respiratory tract infections
Pontus Hedberg, Nicholas Baltzer, Fredrik Granath, Michael Fored, Johan Mårtensson and Pontus Nauclér. Crit Care 2023; https://doi.org/10.1186/s13054-023-04722-0
Outcomes of SARS-CoV-2 Omicron Variant Infections Compared with Seasonal Influenza and Respiratory Syncytial Virus Infections in Adults Attending the Emergency Department: A Multicentre Cohort Study
Pontus Hedberg, John Karlsson Valik, Lina Abdel Halim, Tobias Alfvén, Pontus Naucler. Clinical Infectious Diseases 2023; https://doi.org/10.1093/cid/ciad660
EuCARE-hospitalised study protocol: a cohort study of patients hospitalised with COVID-19 in the EuCARE project
Pontus Hedberg, Benedetta Varisco, Francesca Bai, Anders Sönnerborg, Pontus Naucler, Nico Pfeifer, Alessandro Cozzi‑Lepri, Francesca Ceccherini‑Silberstein, Daniel Naumovas, Francis Drobniewski, Björn‑Erik Ole Jensen, Cristina Toscano, Miłosz Parczewski, Gibran Horemheb Rubio Quintanares, Matilu Mwau, Jorge A. Pinto, Francesca Incardona, Chiara Mommo and Giulia Marchetti. BMC Infectious Diseases 2023; https://doi.org/10.1186/s12879-023-08658-2
EuCARE-POSTCOVID Study: a multicentre cohort study on long-term post-COVID-19 manifestations
Benedetta Varisco, Francesca Bai, Sara De Benedittis, Alessandro Tavelli, Alessandro Cozzi‑Lepri, Matteo Sala, Federica Gaia Miraglia, Maria Mercedes Santoro, Francesca Ceccherini‑Silberstein, Yishai Shimoni, Sivan Ravid, Tal Kozlovski, Florian König, Nico Pfeifer, Elham Shamsara, Milosz Parczewski, Antonella d’Arminio Monforte, Francesca Incardona, Chiara Mommo and Giulia Marchetti. BMC Infect Dis 2023; https://doi.org/10.1186/s12879-023-08595-0
Immunogenicity and clinical effectiveness of mRNA vaccine booster against SARS-CoV-2 Omicron in patients with haematological malignancies: A national prospective cohort study
Lukas Kevličius, Karolis Šablauskas, Kazimieras Maneikis, Dovilė Juozapaitė, Ugnė Ringelevičiūtė, Vilmantė Vaitekėnaitė, Birutė Davainienė, Guoda Daukėlaitė, Dominika Vasilevska, Mindaugas Stoškus, Ieva Narkevičiūtė, Violeta Sivickienė, Kęstutis Rudaitis, Mantas Minkauskas, Daniel Naumovas, Tumas Beinortas, Laimonas Griškevičius . Br J Haematol. 2023; https://doi.org/10.1111/bjh.19126
Neutralizing antibodies response to novel SARS-CoV-2 omicron sublineages in long-term care facility residents after the fourth dose of monovalent BNT162b2 COVID-19 vaccination
Ilenia Varasi, Alessia Lai, Lia Fiaschi, Annalisa Bergna, Antonella Gatti, Barbara Caimi, Camilla Biba, Carla Della Ventura, Claudia Balotta, Agostino Riva, Gianguglielmo Zehender, Maurizio Zazzi and Ilaria Vicenti. The Journal of Infection 2023; https://doi.org/10.1016/j.jinf.2023.06.019
Post COVID-19 condition after SARS-CoV-2 infections during the omicron surge compared with the delta, alpha, and wild-type periods in Stockholm, Sweden
Pontus Hedberg and Pontus Nauclér . The Journal of Infectious Diseases 2023; https://doi.org/10.1093/infdis/jiad382
Sports activity limitation during the COVID-19 pandemic in young Italian athletes: impact on mental health in children, adolescents, and young adults
Elisa Tomezzoli, Oriana D’Ecclesiis, Sara Raimondi, Gabriella Pravettoni, Giulio Cammarata, Giovanna Testa, Federica Bellerba, Patrizia Gnagnarella, Maria Luisa Iannuzzo, Alessandro Sartorio, Clementina Sasso, Dorotea Ricci, Nicoletta Marazzi, Federica Galli and Sara Gandini on behalf of the EuCARE WP4. Front. Public Health 2023; https://doi.org/10.3389/fpubh.2023.1237443
Frequency of Atypical Mutations in the Spike Glycoprotein in SARS-CoV-2 Circulating from July 2020 to July 2022 in Central Italy: A Refined Analysis by Next Generation Sequencing
Maria Concetta Bellocchi, Rossana Scutari, Luca Carioti, Marco Iannetta, Greta Marchegiani, Lorenzo Piermatteo, Luigi Coppola, Simona Tedde, Leonardo Duca, Vincenzo Malagnino, Lorenzo Ansaldo, Neva Braccialarghe, Stefano D’Anna, Maria Mercedes Santoro, Andrea Di Lorenzo, Romina Salpini, Elisabetta Teti, Valentina Svicher, Massimo Andreoni, Loredana Sarmati, Francesca Ceccherini-Silberstein and on behalf of the PTV-UTV-ID-COVID Group. Viruses 2023; https://doi.org/10.3390/v15081711
Sociodemographic disparities affect COVID-19 vaccine uptake in non-elderly adults with increased risk of severe COVID-19
Pontus Hedberg, Adonis Sotoodeh, Helena H. Askling and Pontus Nauclér. J Intern Med 2023; https://doi.org/10.1111/joim.13700
Coinfection with Strongyloides and SARS-CoV-2: A Systematic Review
Elena C. Rosca, Carl Heneghan, Elizabeth A. Spencer, Annette Plüddemann, Susanna Maltoni, Sara Gandini, Igho J. Onakpoya, David Evans, John M. Conly and Tom Jefferson. Trop. Med. Infect. Dis 2023; https://doi.org/10.3390/tropicalmed8050248
SARS-CoV-2 Neutralizing Antibodies to B.1 and to BA.5 Variant after Booster Dose of BNT162b2 Vaccine in HIV Patients COVID-Naïve and on Successful Antiretroviral Therapy
Ilaria Vicenti, Monica Basso, Nicole Pirola, Beatrice Bragato, Maria Cristina Rossi, Mario Giobbia, Susanna Pascoli, Antonio Vinci, Sara Caputo, Ilenia Varasi, Camilla Biba, Lia Fiaschi, Maurizio Zazzi and Saverio Giuseppe Parisi. Vaccines 2023; https://doi.org/10.3390/vaccines11040871
European Cohorts of patients and schools to Advance Response to Epidemics (EuCARE): a cluster randomised interventional and observational study protocol to investigate the relationship between schools and SARS-CoV-2 infection
Sara Raimondi, Sara Gandini, Gibran Horemheb Rubio Quintanares, Ana Abecasis, Pier Luigi Lopalco, Oriana D’Ecclesiis, Susanna Chiocca, Elisa Tomezzoli, Ilaria Cutica, Davide Mazzoni, Nuno Amparo, Marta Pingarilho, Daniela Carmagnola, Claudia Dallavia, Gianvincenzo Zuccotti, Chiara Ronchini, Federica Bellerba, Felix Dewald, Rolf Kaiser, Francesca Incardona and The Eucare WP4. BMC Infectious Diseases 2023; https://doi.org/10.1186/s12879-022-07947-6
Post COVID-19 condition diagnosis: A population-based cohort study of occurrence, associated factors, and healthcare use by severity of acute infection
Pontus Hedberg, Fredrik Granath, Judith Bruchfeld, Johan Askling, Daniel Sjöholm, Michael Fored, Anna Färnert and Pontus Naucler. J Inten Medicine 2022; https://doi.org/10.1111/joim.13584
SARS-CoV-2 nasopharyngeal viral load in individuals infected with BA.2, compared to Alpha, Gamma, Delta and BA.1 variants: A single-center comparative analysis
. Journal of Clinical Virology 2022; https://doi.org/10.1016/j.jcv.2022.105299
Two-Period Study Results from a Large Italian Hospital Laboratory Attesting SARS-CoV-2 Variant PCR Assay Evolution
Flora Marzia Liotti, Flavio De Maio, Chiara Ippoliti, Giulia Santarelli, Francesca Romana Monzo, Michela Sali, Rosaria Santangelo, Francesca Ceccherini-Silberstein, Maurizio Sanguinetti, Brunella Posteraro; Microbiol Spectr. 2022; https://doi.org/10.1128/spectrum.02922-22
Rapid selection of sotrovimab escape variants in SARS-CoV-2 Omicron infected immunocompromised patients
. Clinical Infectious Diseases 2022; https://doi.org/10.1093/cid/ciac802
SARS-CoV-2 Mutations and Variants May Muddle the Sensitivity of COVID-19 Diagnostic Assays
Mohammad Alkhatib, Luca Carioti, Stefano D’Anna, Francesca Ceccherini-Silberstein, Valentina Svicher and Romina Salpini. Microorganisms 2022; https://doi.org/10.3390/microorganisms10081559
Long-Term Longitudinal Analysis of Neutralizing Antibody Response to Three Vaccine Doses in a Real-Life Setting of Previously SARS-CoV-2 Infected Healthcare Workers: A Model for Predicting Response to Further Vaccine Doses
. Vaccines 2022; https://doi.org/10.3390/vaccines10081237
Incidence and severity of COVID‐19 in adults with and without HIV diagnosis
Pontus Hedberg, Jan Vesterbacka, Ola Blennow, Catharina Missailidis, Piotr Nowak and Pontus Naucler. J Intern Med 2022; https://doi.org/10.1111/joim.13481
Impact of SARS-CoV-2 omicron BA.1 and delta AY.4.2 variants on the neutralization by sera of patients treated with different authorized monoclonal antibodies
. Clin Microbiol Infect 2022; https://doi.org/10.1016/j.cmi.2022.03.005
The Impact of Sport Activity Shut down during the COVID-19 Pandemic on Children, Adolescents, and Young Adults: Was It Worthwhile?
Sara Raimondi, Giulio Cammarata, Giovanna Testa, Federica Bellerba, Federica Galli, Maria Luisa Iannuzzo, Dorotea Ricci, Alessandro Sartorio, Clementina Sasso, Gabriella Pravettoni and Sara Gandini. International Journal of Environmental Research and Public Health. 2022; https://doi.org/10.3390/ijerph19137908
Efficacy of Licensed Monoclonal Antibodies and Antiviral Agents against the SARS-CoV-2 Omicron Sublineages BA.1 and BA.2
Lia Fiaschi, Filippo Dragoni, Elisabetta Schiaroli, Annalisa Bergna, Barbara Rossetti, Federica Giammarino, Camilla Biba, Anna Gidari, Alessia Lai, Cesira Nencioni, Daniela Francisci, Maurizio Zazzi and Ilaria Vicenti. Viruses 2022; https://doi.org/10.3390/v14071374
A Tale of Three Recent Pandemics: Influenza, HIV and SARS-CoV-2
Mafalda N. S. Miranda, Marta Pingarilho, Victor Pimentel, Andrea Torneri, Sofia G. Seabra, Pieter J. K. Libin and Ana B. Abecasis. Front. Microbiol 2022; https://doi.org/10.3389/fmicb.2022.889643
SARS-CoV-2 circulation in the school setting: a systematic review and meta-analysis
Saverio Caini, Chiara Martinoli, Carlo La Vecchia, Sara Raimondi, Federica Bellerba, Oriana D’Ecclesiis, Clementina Sasso, Alessandra Basso, Giulio Cammarata, Sara Gandini. International Journal of Environmental Research and Public Health 2022; https://doi.org/10.3390/ijerph19095384
Comparable Post-Vaccination Decay of Neutralizing Antibody Response to Wild-Type and Delta SARS-CoV-2 Variant in Healthcare Workers Recovered from Mild or Asymptomatic Infection
Vaccines 2022; https://doi.org/10.3390/vaccines10040580
Humoral and Cellular Immune Response Elicited by mRNA Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in People Living With Human Immunodeficiency Virus Receiving Antiretroviral Therapy Based on Current CD4 T-Lymphocyte Count
Clin Infect Dis 2022; https://doi.org/10.1093/cid/ciac238
Real World Estimate of Vaccination Protection in Individuals Hospitalized for COVID-19
Antonella d’Arminio Monforte, Alessandro Tavelli, Sara De Benedittis, Francesca Bai, Camilla Tincati, Lidia Gazzola, Ottavia Viganò, Marina Allegrini, Debora Mondatore, Daniele Tesoro, Diletta Barbanotti, Giovanni Mulé, Roberto Castoldi, Anna De Bona, Teresa Bini, Davide Chiumello, Stefano Centanni, Sabrina Passarella, Nicola Orfeo, Giulia Marchetti, Alessandro Cozzi-Lepri and for the SPID Group †. Vaccines 2022; https://doi.org/10.3390/vaccines10040550
Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile
Mohammad Alkhatib, Romina Salpini, Luca Carioti, Francesca Alessandra Ambrosio, Stefano D’Anna, Leonardo Duca, Giosuè Costa, Maria Concetta Bellocchi, Lorenzo Piermatteo, Anna Artese, Maria Mercedes Santoro, Stefano Alcaro, Valentina Svicher, Francesca Ceccherini-Silberstein. Microbiology Spectrum 2022; https://doi.org/10.1128/spectrum.02732-21
COVID-19 Vaccine Hesitancy in Diverse Groups in the UK—Is the Driver Economic or Cultural in Student Populations
Francis Drobniewski, Dian Kusuma, Agnieszka Broda, Enrique Castro-Sánchez and Raheelah Ahmad. Vaccines 2022; https://doi.org/10.3390/
Signals were broadly positive for months, but never definitive: the tocilizumab story
Alessandro Cozzi-Lepri, Colette Smith and Cristina Mussini. Clinical Microbiology and Infection 2022; https://doi.org/10.1016/j.cmi.2021.10.018
First Case of a COVID-19 Patient Infected by Delta AY.4 with a Rare Deletion Leading to a N Gene Target Failure by a Specific Real Time PCR Assay: Novel Omicron VOC Might Be Doing Similar Scenario?
Mohammad Alkhatib, Maria Concetta Bellocchi, Greta Marchegiani, Sandro Grelli, Valeria Micheli, Daniele Stella, Bartolomeo Zerillo, Luca Carioti, Valentina Svicher, Paola Rogliani and Francesca Ceccherini-Silberstein. Microorganisms 2022; https://doi.org/10.3390/ microorganisms10020268
First and second waves among hospitalised patients with COVID-19 with severe pneumonia: a comparison of 28-day mortality over the 1-year pandemic in a tertiary university hospital in Italy
Marianna Meschiari, Alessandro Cozzi-Lepri, Roberto Tonelli, Erica Bacca, Marianna Menozzi, Erica Franceschini, Gianluca Cuomo, Andrea Bedini, Sara Volpi, Jovana Milic, Lucio Brugioni, Elisa Romagnoli, Antonello Pietrangelo, Elena Corradini, Irene Coloretti, Emanuela Biagioni, Stefano Busani, Massimo Girardis, Andrea Cossarizza, Enrico Clini, Giovanni Guaraldi, Cristina Mussini, Modena COVID-19 Working Group (MoCo19). BMJ Open 2022; doi:10.1136/bmjopen-2021-054069